ECO Animal Health Group’s (EAH) Buy Rating Reiterated at Shore Capital

Shore Capital reiterated their buy rating on shares of ECO Animal Health Group (LON:EAH) in a research note issued to investors on Monday morning, MarketBeat.com reports.

ECO Animal Health Group Stock Performance

ECO Animal Health Group stock opened at GBX 57.25 ($0.74) on Monday. The company has a market cap of £38.79 million, a PE ratio of 37.01 and a beta of -0.05. The company has a current ratio of 2.96, a quick ratio of 2.14 and a debt-to-equity ratio of 4.81. ECO Animal Health Group has a 1 year low of GBX 51 ($0.66) and a 1 year high of GBX 135 ($1.74). The company’s 50-day moving average is GBX 60.32 and its two-hundred day moving average is GBX 71.38.

ECO Animal Health Group Company Profile

ECO Animal Health is a world leader in animal health, developing and marketing branded veterinary pharmaceuticals globally, with expertise in antibiotics and vaccines for pigs and poultry. We have a maturing proprietary R&D pipeline.

Headquartered in the UK, with global offices including R&D and manufacturing, we have marketing authorisations in over 70 countries and employ over 200 people worldwide.

Our lead product, Aivlosin® is a proprietary, patented medication which is effective against both respiratory and intestinal diseases in pigs and poultry.